GDRX — GoodRx Holdings, Inc.
—
Nasdaq ·
Information Technology ·
IT Services ·
CIK 1809519 ·
Last close
$3.44
Market Cap
$368.70M
52W High
$3.89
52W Low
$2.48
ADV30
1,577,916
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 200,411,000 | 179,412,000 | 23,632,000 | 8,536,000 | 2,342,928,000 | 296,113,000 | 1,695,327,000 |
| Mar 2026 | 194,006,000 | 173,850,000 | 14,009,000 | 1,169,000 | 2,021,251,000 | 235,710,000 | 1,399,265,000 |
| Dec 2025 | 194,785,000 | 177,321,000 | 22,683,000 | 5,425,000 | 1,404,058,000 | 261,820,000 | 787,796,000 |
| Sep 2025 | 196,028,000 | 182,609,000 | 14,620,000 | 1,119,000 | 1,325,507,000 | 273,529,000 | 724,795,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$201,581,000
Investing CF
$-85,822,000
Financing CF
$-100,964,000
CapEx
$-69,882,000
Dividends Paid
—
Buybacks
$-85,004,000
EPS Diluted TTM
$0.04
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,400,869,000
Inventory
—
Receivables
$182,140,000
ST Investments
—
EBIT TTM
$82,207,000
Pretax Income TTM
$41,398,000
Interest Exp TTM
$40,809,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$785,230,016
EBITDA
$108,776,000
Free Cash Flow
$112,499,128
Enterprise Value
$1,419,788,544
Total Cash
$296,112,992
Total Debt
$538,950,016
Shares Out
107,181,201
Trailing EPS
$0.06
Book Value
$1.90
ROE
2.5%
ROA
3.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 796,853,000 | 87,492,000 | 30,439,000 | 1,404,058,000 | 787,796,000 | — | 167,904,000 |
| Dec 2024 | 792,324,000 | 65,846,000 | 16,390,000 | 1,388,067,000 | 663,409,000 | — | 183,892,000 |
| Dec 2023 | 750,265,000 | -27,007,000 | -8,868,000 | 1,588,800,000 | 826,842,000 | — | 138,292,000 |
| Dec 2022 | 766,554,000 | 1,738,000 | -32,828,000 | 1,604,631,000 | 789,804,000 | — | 146,780,000 |
TTM Snapshot
Revenues TTM
$562,527,000
NetIncome TTM
$-76,264,000
OpCashFlow TTM
$0
Assets (Latest)
$1,388,067,000
Forward EPS
$0.36
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $3.44 · call volume: 270 · put volume: 3
Expected Move to 2026-09-18:
±$1.16
(33.72%) —
implied range
$2.28 –
$4.60
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SLP | Simulations Plus, Inc. | $372.14M | $18.40 | — |
| RBBN | Ribbon Communications Inc. | $364.80M | $2.04 | — |
| AIAI | AIAI Holdings Corp | $375.22M | $5.31 | — |
| BMBL | Bumble Inc. | $376.11M | $2.85 | — |
| ECX | ECARX Holdings Inc. | $378.26M | $1.09 | — |
News headlines (Yahoo Finance, 1h cache)
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX)
2026-08-14 15:49 · Yahoo
GoodRx (GDRX) Stock Looks Overvalued On Its Earnings Outlook
2026-08-13 08:09 · Yahoo
GoodRx Holdings (GDRX) Could Be 13% Overvalued After Q2 Earnings and Guidance Raise
2026-08-13 07:51 · Yahoo
GoodRx (GDRX) Q2 2026 Earnings Call Transcript
2026-08-12 23:03 · Yahoo
GoodRx subscription revenue surges 39% as company expands beyond prescriptions
2026-08-10 20:58 · Yahoo
1 Stock Under $10 with Exciting Potential and 2 Facing Headwinds
2026-08-10 20:05 · Yahoo
GoodRx Q2 Earnings Call Highlights
2026-08-06 18:04 · Yahoo
GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
2026-08-06 00:30 · Yahoo
1 Profitable Stock for Long-Term Investors and 2 Facing Challenges
2026-07-17 09:29 · Yahoo
GDRX Q2 Deep Dive: Pharma Direct and Subscription Growth Drive Upgraded Outlook
2026-08-11 15:09 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.